Laura De Matteis

Laura De Matteis

Auto-generated profile, based on publicly available information

Laura De Matteis

Instituto de Nanociencia de Aragón Universidad de Zaragoza C/ Mariano Esquillor s/n 50018 Zaragoza Spain

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2017 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
SHSven Herrmann
Sven Herrmann
LMLaura De Matteis
Laura De Matteis
Jesus M De La FuenteJesus M De La Fuente
Jesus M De La Fuente
SMScott G Mitchell
Scott G Mitchell
CSCarsten Streb
Carsten Streb

5 February 2016 in The Journal of Physical Chemistry C
Verified
Journal Article
Closed access
XLXabier Lasheras
Xabier Lasheras
MIMaite Insausti
Maite Insausti
IMIzaskun Gil de Muro
Izaskun Gil de Muro
EGEneko Garaio
Eneko Garaio
FPFernando Plazaola
Fernando Plazaola
LLLuis Lezama
Luis Lezama

22 May 2014 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
Nicolas RispailNicolas Rispail
Nicolas Rispail
LMLaura De Matteis
Laura De Matteis
RSRaquel Santos
Raquel Santos
AMAna S. Miguel
Ana S. Miguel
LCLaura Custardoy
Laura Custardoy
EPElena Prats
Elena Prats

1 September 2014 in International Journal of Nanomedicine
Verified
Journal Article
Open access
Julio GalvezJulio Galvez
Julio Galvez
ARAlba Rodriguez-Nogales
Alba Rodriguez-Nogales
VOVictor Ortiz
Victor Ortiz
FAFrancesca Algieri
Francesca Algieri
PZPedro Zorrilla
Pedro Zorrilla
Antonio Abel Lozano-PérezAntonio Abel Lozano-Pérez
Antonio Abel Lozano-Pérez
Purpose: We aimed to evaluate the intestinal anti-inflammatory properties of silk fibroin nanoparticles, around 100 nm in size, when loaded with the stilbene compound resveratrol, in an experimental model of rat colitis. Methods: Nanoparticles were loaded with resveratrol by adsorption. The biological effects of the resveratrol-loaded nanoparticles were tested both in vitro, in a cell culture of RAW 264.7 cells (mouse macrophages), and in vivo, in the trinitrobenzenesulfonic acid model of rat colitis, when administered intracolonically. Results: The resveratrol liberation in 1× phosphate-buffered saline (PBS; pH 7.4) was characterized by fast liberation, reaching the solubility limit in 3 hours, which was maintained over a period of 80 hours. The in vitro assays revealed immunomodulatory properties exerted by these resveratrol-loaded nanoparticles since they promoted macrophage activity in basal conditions and inhibited this activity when stimulated with lipopolysaccharide. The in vivo experiments showed that after evaluation of the macroscopic symptoms, inflammatory markers, and intestinal barrier function, the fibroin nanoparticles loaded with resveratrol had a better effect than the single treatments, being similar to that produced by the glucocorticoid dexamethasone. Conclusion: Silk fibroin nanoparticles constitute an attractive strategy for the controlled release of resveratrol, showing immunomodulatory properties and intestinal anti-inflammatory effects.

1 November 2016 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
ARAlba Rodriguez-Nogales
Alba Rodriguez-Nogales
FAFrancesca Algieri
Francesca Algieri
LMLaura De Matteis
Laura De Matteis
Antonio Abel Lozano-PérezAntonio Abel Lozano-Pérez
Antonio Abel Lozano-Pérez
JMJosé Garrido Mesa
José Garrido Mesa
Maria Elena Rodriguez-CabezasMaria Elena Rodriguez-Cabezas
Maria Elena Rodriguez-Cabezas
Background: Current treatment of inflammatory bowel disease is based on the use of immunosuppressants or anti-inflammatory drugs, which are characterized by important side effects that can limit their use. Previous research has been performed by administering these drugs as nanoparticles that target the ulcerated intestinal regions and increase their bioavailability. It has been reported that silk fibroin can act as a drug carrier and shows anti-inflammatory properties. Purpose: This study was designed to enhance the interaction of the silk fibroin nanoparticles (SFNs) with the injured intestinal tissue by functionalizing them with the peptide motif RGD (arginine–glycine–aspartic acid) and to evaluate the intestinal anti-inflammatory properties of these RGD-functionalized silk fibroin nanoparticles (RGD-SFNs) in the trinitrobenzenesulfonic acid (TNBS) model of rat colitis.
Materials and methods:
SFNs were prepared by nanoprecipitation in methanol, and the linear RGD peptide was linked to SFNs using glutaraldehyde as the crosslinker. The SFNs (1 mg/rat) and RGD-SFNs (1 mg/rat) were administered intrarectally to TNBS-induced colitic rats for 7 days. Results: The SFN treatments ameliorated the colonic damage, reduced neutrophil infiltration, and improved the compromised oxidative status of the colon. However, only the rats treated with RGD-SFNs showed a significant reduction in the expression of different pro-inflammatory cytokines (interleukin [IL]-1β, IL-6, and IL-12) and inducible nitric oxide synthase in comparison with the TNBS control group. Moreover, the expression of both cytokine-induced neutrophil chemoattractant-1 and monocyte chemotactic protein-1 was significantly diminished by the RGD-SFN treatment. However, both treatments improved the intestinal wall integrity by increasing the gene expression of some of its markers (trefoil factor-3 and mucins).
Conclusion:
SFNs displayed intestinal anti-inflammatory properties in the TNBS model of colitis in rats, which were improved by functionalization with the RGD peptide.

23 January 2012 in Chemistry of Materials
Verified
Journal Article
Closed access
LMLaura De Matteis
Laura De Matteis
LCLaura Custardoy
Laura Custardoy
RFRodrigo Fernández-Pacheco
Rodrigo Fernández-Pacheco
Cesar MagenCesar Magen
Cesar Magen
Jesus M De La FuenteJesus M De La Fuente
Jesus M De La Fuente
MIM. Ricardo Ibarra
M. Ricardo Ibarra